Country | Included references | Selected references | Sample size | Anti-HCV prevalence (%) (95% CI) | Baseline sample size | Baseline prevalence (%) (95% CI) |
---|---|---|---|---|---|---|
General population | ||||||
 Spain | 3 | Single low risk | 13678 | 0.8 (0.65–0.95) [20] | 364 | 1.1(0.3–2.8) [17] |
 Italy | 2 | Pooled low risk | 12444 | 4826 | 5.9(5.2–6.6) [17] | |
 Poland | 2 | Single high risk | 61805 | 1.5 (1.4–1.6) [24] | – | – |
 Czech Republic | 1 | Single low risk | 3000 | 1.67 (1.21–2.13) [27] | – | – |
 Portugal | 1 | Single low risk | 1627 | 0.54 (0.18–0.9) [28] | – | – |
 Netherlands | 1 | Single high risk | 6036 | 0.56 (0.37–0.75) [33] | 4046 | 0.1(0.0–0.2) [17] |
 Ireland | 1 | Single low risk | 3795 | 0.98 (0.67–1.29) [26] | 1478 | 0.1(0.0–0.4) [17] |
Pregnant women | ||||||
 UK | 2 | Single low risk | 31467 | 0.1 (0.06–0.13) [31] | 110621 | 1 [17] |
 Slovenia | 1 | Single low risk | 31849 | 0.13 (0.09–0.17) [32] | 90 | 4.4 [17] |
 Italy | 1 | Single high risk | 5184 | 0.2 (0.08–0.32) [33] | 10881 | 1.7 (1.4–1.9) [17] |
 Poland | 1 | Single low risk | 38309 | 0.76 (0.67–0.85) [34] | 1534 | 0.1 (0.0–0.3) [17] |
 Sweden | 1 | Single low risk | 4112 | 0.27 (0.11–0.43) [35] | – | – |
 Spain | 1 | Single low risk | 21379 | 0.55 (0.45–0.65) [36] | – | – |
First-time blood donors | ||||||
 Italy | 1 | Single low risk | 1934612 | 0.09 (0.08–0.09) [37] | – | 0.094 (0.085–0.104) [17] |
 Greece | 1 | Single high risk | 3838919 | 0.03 (0.03–0.03) [38] | – | 1.202 (1.114–1.295) [17] |
MSM | ||||||
 Netherlands | 1 | Single high risk | 439 | 7.1 (4.69–9.51) [40] | – | – |
 UK | 1 | Single low risk | 1140 | 1.8 (1.03–2.57) [39] | – | – |
 France | 1 | Single low risk | 13051 | 5.1 (4.72–5.48) [41] | – | – |
Prisoner | ||||||
 UK | 2 | Pooled high risk | 1484 | 5450 | 17.7(16.4–18.4) [18] | |
 Portugal | 2 | Pooled high risk | 82 | 151 | 34.4(26.9–42.6) [18] | |
 Norway | 1 | Single high risk | 62 | 51.6 (39.06–64.14) [63] |  |  |
 Spain | 1 | Single high risk | 436 | 16 (12.55–19.45) [47] | – | 22.7(18.3–27.1) [18] |
PWID | ||||||
 UK | 3 | Pooled low risk | 1818 | 3144 | 49.1 (47.4–50.9) [18] | |
 France | 2 | Pooled low risk | 3015 | – | – | |
 Spain | 2 | Single low risk | 754 | 72 (68.79–75.21) [52] | – | – |
 Greece | 2 | Pooled high risk | 3099 | 1309 | 68.1 (65.5–70.6) [18] | |
Germany | 1 | Pooled low risk from a single study | 1526 | 66.18 (63.8–68.55) [57] | – | – |
 Italy | 1 | Single high risk | 261 | 47.1 (41.03–53.17) [64] | 743 | 60.5 (56.8–64.0) [18] |
 Hungary | 1 | Single low risk | 755 | 48.24 (44.67–51.81) [58] | 652 | 24.1 (20.8–27.6) [18] |
 Croatia | 1 | Pooled low risk from a single study | 830 | 34.04 (30.81–37.26) [59] | 200 | 44 (37.0–51.2) [18] |
 Sweden | 1 | Single high risk | 1386 | 82 (79.98–84.02) [60] | – | – |
 Ireland | 1 | Single high risk | 228 | 63.6 (57.34–69.86) [61] | 200 | 41.5 (34.6–48.7) [18] |
 Bosnia and Herzegovina | 1 | Single high risk | 120 | 52.5 (43.53–61.47) [62] | – | – |
 Norway | 1 | Single high risk | 304 | 41 (35.46–46.54) [63] | 6342 | 63.0 (61.8–64.2) |